Tronox TROX 深 沪
等待开盘 07-08 09:30:00 美东时间
6.12
+0.090
+1.49%
华盛通- 最 高6.20
- 今 开5.96
- 成交量 221.73万股
- 最 低 5.84
- 昨 收 6.03
- 总市值 9.76亿
- 52周最高 10.54
- 市盈率 静 --
- 换手率 1.39%
- 52周最低 2.71
- 委 比 -83.57%
- 总股本 1.60亿
- 历史最高 184.985
- 量 比 0.79
- 振 幅 5.97%
- 历史最低 -0.73
- 每 手 1
- 风险率 2.11%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 甲骨文绩后分歧大！5家上调，2家下调；Navan、Hinge Health、凯西通用获多家大行上调目标价
今日重点评级关注：Ascendiant Capital：维持Outlook Therapeutics"买入"评级，目标价从6美元升至10美元；Ascendiant Capital：维持Aytu BioPharma"买入"评级，目标价从14美元升至14.5美元
06-12 11:32
This Henry Schein Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. B of A Securities analyst Ross Fowler upgraded Black Hills Corp (NYSE:BKH) from Neutral to Buy an...
06-11 20:05
Truist Securities Upgrades Tronox Holdings to Hold, Maintains Price Target to $7
Truist Securities analyst Peter Osterland upgrades Tronox Holdings (NYSE:TROX) from Sell to Hold and maintains the price target from $7 to $7.
06-11 19:41
美股大行评级 | 富国银行上调英伟达目标价从265美元升至315美元；Alamar、AEVEX获多家大行首予“买入”评级
今日重点评级关注：Needham：维持Artiva Biotherapeutics"买入"评级，目标价从18美元升至41美元；HC Wainwright & Co.：维持SAB Biotherapeutics"买入"评级，目标价从7美元升至10美元
05-13 11:46
Goldman Sachs Downgrades Tronox Holdings to Sell, Announces $9 Price Target
Goldman Sachs analyst Duffy Fischer downgrades Tronox Holdings (NYSE:TROX) from Buy to Sell and announces $9 price target.
05-13 01:59
美股大行评级 | 爱彼迎、Affirm、CoreWeave、Datadog、微芯科技等获多家大行上调目标价；HubSpot惨遭14家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从15美元升至35美元；韦德布什：维持Cullinan Therapeutics"跑赢大市"评级，目标价从36美元升至37美元
05-11 15:43
Tronox Holdings shares are trading lower after the company reported worse-than-expected Q1 adjusted EPS results.
Tronox Holdings shares are trading lower after the company reported worse-than-...
05-08 00:05
Tronox Holdings Q1 Adj. EPS $(0.55) Misses $(0.45) Estimate, Sales $760.000M Beat $753.440M Estimate
Tronox Holdings (NYSE:TROX) reported quarterly losses of $(0.55) per share which missed the analyst consensus estimate of $(0.45) by 22.22 percent. This is a 266.67 percent decrease over losses of $(0.15) per share from
05-07 05:49
Earnings Scheduled For May 6, 2026
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
